Skip to main content

Table 2 Pre-treatment Clinical Risk Assessment

From: Prospective study evaluating dynamic changes of cell-free HPV DNA in locoregional viral-associated oropharyngeal cancer treated with induction chemotherapy and response-adaptive treatment

Clinical Risk Assessment (based on pre-treatment assessment)
Low Risk (All of the below) High Risk (Any of the below)
T0-T3 T4
N0-N1 N2-3 (or nodal conglomerate \(\ge\) 6 cm)
\(\le\) 20 pack year smoking history  > 20 pack year smoking history
HPV16 subtype HPV18 subtype